Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer (Scientific Reports, (2018), 8, 1, (73), 10.1038/s41598-017-17913-x)

T. Boulding, R. D. McCuaig, A. Tan, K. Hardy, F. Wu, J. Dunn, M. Kalimutho, Christopher Sutton, J. K. Forwood, A. G. Bert, G. J. Goodall, L. Malik, D. Yip, J. E. Dahlstrom, A. Zafar, K. K. Khanna, S. Rao

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
2 Downloads (Pure)

Abstract

In this Article, the authors neglected to include some potential conflicts of interest. The Competing Interests section should read: “In accordance with NHMRC policy and our ethical obligations as researchers, we report that the University of Canberra, Rao, McCuaig, Tan and Zafar have a financial interest in EpiAxis Therapeutics Pty Ltd and Forwood receive funding from EpiAxis Therapeutics Pty Ltd. Rao is also Chief Scientific Officer of EpiAxis Therapeutics Pty Ltd. We also have in place a plan for managing any potential conflicts arising from that involvement.”.

Original languageEnglish
Article number18771
Pages (from-to)1-1
Number of pages1
JournalScientific Reports
Volume9
Issue number1
DOIs
Publication statusPublished - 01 Dec 2019

Fingerprint Dive into the research topics of 'Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer (Scientific Reports, (2018), 8, 1, (73), 10.1038/s41598-017-17913-x)'. Together they form a unique fingerprint.

  • Cite this

    Boulding, T., McCuaig, R. D., Tan, A., Hardy, K., Wu, F., Dunn, J., Kalimutho, M., Sutton, C., Forwood, J. K., Bert, A. G., Goodall, G. J., Malik, L., Yip, D., Dahlstrom, J. E., Zafar, A., Khanna, K. K., & Rao, S. (2019). Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer (Scientific Reports, (2018), 8, 1, (73), 10.1038/s41598-017-17913-x). Scientific Reports, 9(1), 1-1. [18771]. https://doi.org/10.1038/s41598-019-55020-1